[目前的高级高度血清性卵巢癌的管理]
Yves Durand1, Marie Nicod Lalonde2, Delfyne Hastir3
1Service de gynécologie, Centre hospitalier universitaire vaudois et Université de Lausanne, 1011 Lausanne.
Revue medicale suisse
|October 21, 2024
概括
卵巢癌,通常起源于输卵管,由于非特异性症状和缺乏有效查, presents一个诊断挑战. 尽管取得了进展,但这些妇科癌症的预后仍然很差.
科学领域:
- 妇科瘤学 妇科瘤学
- 医疗成像医学成像
背景情况:
- 卵巢癌,主要是高等级的血清性癌,通常起源于输卵管.
- 这些癌症的整体预后很差,尽管最近的治疗进展.
- 非特定的临床表现和没有经过验证的查测试导致晚期诊断.
研究的目的:
- 审查卵巢癌的诊断方式.
- 突出高级成像在分期和随访中的作用.
- 为了强调改善患者治疗结果的持续挑战.
主要方法:
- 审查目前用于卵巢癌的诊断技术.
- 强调成像方式,包括超声波,CT,MRI和PET-CT.
- 讨论从初始呈现到分期的诊断途径.
主要成果:
- 超声波和腹腔盆腔CT扫描是主要的诊断工具,由于可访问性.
- 核磁共振和PET-CT对评估癌症的程度和监测治疗反应越来越重要.
- 尽管成像技术取得了进步,但迟到的诊断仍然是一个重大问题.
结论:
- 卵巢癌的诊断严重依赖于成像,并倾向于采用先进的技术.
- 早期检测仍然是一个关键的未满足的需要,以改善与卵巢癌相关的不良预后.
- 对有效查和早期诊断标志物的进一步研究是必不可少的.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...